CCND1 and colonic neoplasm: Absenger et al. [66] conducted a study concerning cyclin D1 (CCND1) rs9344 G>A polymorphism predicting clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy in stage II/III.